HomeCompareESRX vs RYLD

ESRX vs RYLD: Dividend Comparison 2026

ESRX yields 2.17% · RYLD yields 12.39%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RYLD wins by $22.4K in total portfolio value
10 years
ESRX
ESRX
● Live price
2.17%
Share price
$92.33
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.17
Full ESRX calculator →
RYLD
RYLD
● Live price
12.39%
Share price
$14.64
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.3K
Annual income
$2,682.98
Full RYLD calculator →

Portfolio growth — ESRX vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodESRXRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ESRX + RYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ESRX pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESRX
Annual income on $10K today (after 15% tax)
$184.12/yr
After 10yr DRIP, annual income (after tax)
$211.79/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,053.44/yr
After 10yr DRIP, annual income (after tax)
$2,280.53/yr
At 15% tax rate, RYLD beats the other by $2,068.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESRX + RYLD for your $10,000?

ESRX: 50%RYLD: 50%
100% RYLD50/50100% ESRX
Portfolio after 10yr
$34.1K
Annual income
$1,466.07/yr
Blended yield
4.30%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESRX buys
0
RYLD buys
0
No recent congressional trades found for ESRX or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricESRXRYLD
Forward yield2.17%12.39%
Annual dividend / share$2.00$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$22.9K$45.3K
Annual income after 10y$249.17$2,682.98
Total dividends collected$2.3K$19.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ESRX vs RYLD ($10,000, DRIP)

YearESRX PortfolioESRX Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$10,917$216.61$11,939$1,239.34$1.0KRYLD
2$11,902$221.00$14,158$1,382.89$2.3KRYLD
3$12,960$225.18$16,682$1,532.59$3.7KRYLD
4$14,096$229.16$19,537$1,687.64$5.4KRYLD
5$15,316$232.95$22,752$1,847.20$7.4KRYLD
6$16,625$236.55$26,355$2,010.43$9.7KRYLD
7$18,029$239.96$30,376$2,176.45$12.3KRYLD
8$19,534$243.20$34,847$2,344.43$15.3KRYLD
9$21,147$246.26$39,800$2,513.54$18.7KRYLD
10$22,877$249.17$45,269$2,682.98$22.4KRYLD

ESRX vs RYLD: Complete Analysis 2026

ESRXStock

Express Scripts is a pharmacy benefit management (PBM) organization founded in 1986. It offers integrated services like pharmacy claims processing, home delivery, formulary management, specialty pharmacy via Accredo, and data-driven drug utilization insights. The company is a subsidiary of Cigna following a $54 billion acquisition completed in December 2018.

Full ESRX Calculator →

RYLDETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this ESRX vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESRX vs SCHDESRX vs JEPIESRX vs OESRX vs KOESRX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.